|
|
 |
|
Total Number of Holdings (excluding cash): 50
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$93,574.76 |
2.93% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$89,259.54 |
2.79% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$86,656.15 |
2.71% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$82,521.60 |
2.58% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$80,539.78 |
2.52% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$80,054.14 |
2.51% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$79,369.11 |
2.48% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$77,120.64 |
2.41% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$76,380.76 |
2.39% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$76,149.72 |
2.38% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$75,068.40 |
2.35% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$74,733.75 |
2.34% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$74,417.59 |
2.33% |
| Waters Corporation |
WAT |
941848103 |
184 |
$73,830.00 |
2.31% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$72,019.29 |
2.25% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$70,070.01 |
2.19% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$69,506.72 |
2.18% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$69,054.14 |
2.16% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$68,871.86 |
2.16% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$67,699.12 |
2.12% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$66,255.84 |
2.07% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$65,696.16 |
2.06% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$64,917.55 |
2.03% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$62,985.15 |
1.97% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$62,729.28 |
1.96% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$62,761.95 |
1.96% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$62,252.84 |
1.95% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$61,869.80 |
1.94% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$61,634.05 |
1.93% |
| Steris Plc |
STE |
G8473T100 |
265 |
$61,583.35 |
1.93% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$60,839.07 |
1.90% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$59,146.93 |
1.85% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$58,612.41 |
1.83% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$57,805.50 |
1.81% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$57,658.38 |
1.80% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$57,089.40 |
1.79% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$56,754.84 |
1.78% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$56,137.13 |
1.76% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$56,358.88 |
1.76% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$56,364.24 |
1.76% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$52,838.03 |
1.65% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$52,209.33 |
1.63% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$50,853.40 |
1.59% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$48,416.13 |
1.52% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$48,413.78 |
1.52% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$48,198.85 |
1.51% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$47,085.05 |
1.47% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$44,409.00 |
1.39% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$41,901.28 |
1.31% |
| US Dollar |
$USD |
|
13,565 |
$13,565.44 |
0.42% |
| Yuan Renminbi |
$CNY |
|
1,824 |
$270.49 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|